What are the responsibilities and job description for the Senior Director, Rewriting Discovery position at Tessera Therapeutics?
Your Experience Includes…
You are an engaged leader who is interested in overseeing all of discovery for Tessera’s Rewriter programs. Your experience encompasses leading early-stage programs that have advanced through nonclinical development to the clinic. You have a proven track record of translating novel biology or platform technologies to generate compelling therapeutic candidates. You have experience leading a team of dynamic, multidisciplinary scientists and are interested in driving direction for an early pipeline of high impact programs.
Tessera leaders are empathetic and transparent coaches with a strong sense of integrity. They are committed to the growth and development of their teams, the organization and themselves.
Leadership Structure:
All inquiries regarding the posted position should be directed to the Talent Partner (see below). Interested individuals must apply directly to be considered for the opening.
This position reports to:
Bill Querbes – Senior Vice President, Therapeutics Discovery and Translational Sciences
Meet our Leadership Team and Board of Directors
Meet your Talent Partner:
Narissa Furtado-Cordeiro - Manager, Talent Acquisition
Tessera offers a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits currently include group medical, vision and dental coverage, group life and disability insurance, 401(k) with company contribution, tuition reimbursement, and much more.
Company Summary:
Tessera Therapeutics is pioneering Gene Writing™— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
More about Tessera Therapeutics:
Tessera is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, marital status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate. Tessera provides reasonable accommodations to qualified applicants and employees with disabilities. To begin an interactive dialogue with Tessera regarding a reasonable accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied, please contact the recruiter or Accommodations@tesseratx.com
Recruitment & Staffing Agencies: Tessera Therapeutics does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Tessera Therapeutics or its employees is strictly prohibited unless contacted directly by Tessera Therapeutics’ internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Tessera Therapeutics, and Tessera Therapeutics will not owe any referral or other fees with respect thereto.
- PhD. in Synthetic Biology, Cell Biology, Genetics, Molecular Biology, Biochemistry, Systems Biology, Immunology, or related field with 12 years of industry experience in preclinical candidate development focused on genetic disease.
- Direct industry experience in genetic medicines, gene therapy or gene editing technologies.
- Team leadership experience with a demonstrated track record of personnel development including multiple PhD level scientists.
- It’s a bonus if you have mRNA, or siRNA/ASO experience or have worked with non-viral delivery methods (eg lipid nanoparticles).
- Working closely with the platform team to engineer Gene Rewriting therapeutic candidates.
- Leading preclinical therapeutic development programs through large animal studies.
- Overseeing disease model and analytical assay development.
- Contributing to IND/CTA applications and other regulatory findings.
You are an engaged leader who is interested in overseeing all of discovery for Tessera’s Rewriter programs. Your experience encompasses leading early-stage programs that have advanced through nonclinical development to the clinic. You have a proven track record of translating novel biology or platform technologies to generate compelling therapeutic candidates. You have experience leading a team of dynamic, multidisciplinary scientists and are interested in driving direction for an early pipeline of high impact programs.
Tessera leaders are empathetic and transparent coaches with a strong sense of integrity. They are committed to the growth and development of their teams, the organization and themselves.
Leadership Structure:
All inquiries regarding the posted position should be directed to the Talent Partner (see below). Interested individuals must apply directly to be considered for the opening.
This position reports to:
Bill Querbes – Senior Vice President, Therapeutics Discovery and Translational Sciences
Meet our Leadership Team and Board of Directors
Meet your Talent Partner:
Narissa Furtado-Cordeiro - Manager, Talent Acquisition
Tessera offers a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits currently include group medical, vision and dental coverage, group life and disability insurance, 401(k) with company contribution, tuition reimbursement, and much more.
Company Summary:
Tessera Therapeutics is pioneering Gene Writing™— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
More about Tessera Therapeutics:
Tessera is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, marital status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate. Tessera provides reasonable accommodations to qualified applicants and employees with disabilities. To begin an interactive dialogue with Tessera regarding a reasonable accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied, please contact the recruiter or Accommodations@tesseratx.com
Recruitment & Staffing Agencies: Tessera Therapeutics does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Tessera Therapeutics or its employees is strictly prohibited unless contacted directly by Tessera Therapeutics’ internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Tessera Therapeutics, and Tessera Therapeutics will not owe any referral or other fees with respect thereto.
